Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy

Thomford, 1965, The surgical treatment of metastatic tumors of the lung, J Thorac Cardiovasc Surg, 49, 357, 10.1016/S0022-5223(19)33271-4

Friedel, 1999, Et al., Zentralbl Chir, 124, 96

Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097/00000658-199909000-00004

Louie, 2015, Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons, Radiother Oncol, 114, 138, 10.1016/j.radonc.2014.11.036

Soldà, 2013, Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort, Radiother Oncol, 109, 1, 10.1016/j.radonc.2013.09.006

Brada, 2015, SABR in NSCLC–the beginning of the end or the end of the beginning?, Radiother Oncol, 114, 135, 10.1016/j.radonc.2015.01.012

Guckenberger, 2013, Safety and efficacy of stereotactic body radiotherapy for stage I non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis, J Thorac Oncol, 8, 1050, 10.1097/JTO.0b013e318293dc45

Haedinger, 2005, Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets, Int J Radiat Oncol Biol Phys, 61, 239, 10.1016/j.ijrobp.2004.03.028

Gelman, 2008, A weakly informative default prior distribution for logistic and other regression models, Ann Appl Stat, 2, 1360, 10.1214/08-AOAS191

Gelman, 2008, Scaling regression inputs by dividing by two standard deviations, Stat Med, 27, 2865, 10.1002/sim.3107

Anderson, 2008

Gelman, 2006

Guckenberger, 2009, Dose–response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation, Int J Radiat Oncol Biol Phys, 74, 47, 10.1016/j.ijrobp.2008.06.1939

McCammon, 2009, Observation of a dose–control relationship for lung and liver tumors after stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 73, 112, 10.1016/j.ijrobp.2008.03.062

Stinauer, 2011, Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control, Radiat Oncol, 6, 34, 10.1186/1748-717X-6-34

Stragliotto, 2012, A retrospective study of SBRT of metastases in patients with primary sarcoma, Med Oncol, 29, 3431, 10.1007/s12032-012-0256-2

Takeda, 2011, Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer, Radiother Oncol, 101, 255, 10.1016/j.radonc.2011.05.033

Casiraghi, 2011, A 10-year single-center experience on 708 lung metastasectomies: the evidence of the “international registry of lung metastases”, J Thorac Oncol, 6, 1373, 10.1097/JTO.0b013e3182208e58

Thibault, 2014, Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution’s comprehensive experience, Clin Oncol (R Coll Radiol), 26, 713, 10.1016/j.clon.2014.06.018

Binkley, 2015, Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy, Int J Radiat Oncol, 92, 1044, 10.1016/j.ijrobp.2015.04.004

Filippi, 2015, Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study, Int J Radiat Oncol, 91, 524, 10.1016/j.ijrobp.2014.10.046

Fode, 2015, Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases, Radiother Oncol, 114, 155, 10.1016/j.radonc.2014.12.003

De La Rosa, 2014, Non-small cell lung cancer molecular alterations impact on brain metastases response to gamma knife radiosurgery: identification of potential radiosensitive tumor phenotypes, Neurochirurgie, 60, 333, 10.1016/j.neuchi.2014.10.033

McGarry, 2005, Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study, Int J Radiat Oncol Biol Phys, 63, 1010, 10.1016/j.ijrobp.2005.03.073

Milano, 2008, A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions, Cancer, 112, 650, 10.1002/cncr.23209

Rusthoven, 2009, Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases, J Clin Oncol, 27, 1579, 10.1200/JCO.2008.19.6386

Salama, 2012, Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, 118, 2962, 10.1002/cncr.26611

Iyengar, 2014, Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer, J Clin Oncol, 32, 3824, 10.1200/JCO.2014.56.7412

Guckenberger, 2013, Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer, Radiother Oncol, 109, 13, 10.1016/j.radonc.2013.09.005